Dr. Rosenblatt has more than 30 years of clinical and biomedical research and development experience in multiple settings, including academia, biotech, startups, and clinical practice, and he has published over 80 papers and book chapters on cancer and neuronal biology, biomarker development, and clinical genomics and proteomics. Currently, he is President and Medical Director of Consultative Genomics, PLLC, a molecular pathology group specializing in Genomic and Proteomic clinical testing as applied to chronic disease, population health management, and personalized medicine.